3SBio (TRSBF) Short Interest


TRSBF 3SBio Inc TRSBF
90 GF Score
Price $2.15
GF Value $1.61
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is 3SBio Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TRSBF vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, 3SBio's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3SBio Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio's Short Interest distribution charts can be found below:

* The bar in red indicates where 3SBio's Short Interest falls into.


TRSBF
90GF Score
3SBio Inc TRSBF
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is 3SBio (TRSBF) Overvalued in 2026?

Based on GuruFocus' analysis, 3SBio stock appears to be overvalued. The current stock price of $2.15 is trading 33.5% above its estimated GF Value™ of $1.61. GuruFocus considers 3SBio to be Significantly Overvalued.

Key valuation signals for TRSBF:

  • Short Interest:
  • GF Value™: $1.61 vs. price of $2.15 (33.5% above fair value)
  • GF Score™: 90/100 with 1 warning sign

No single metric tells the full story. See the TRSBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3SBio Business Description

Other Exchanges 01530:Hong Kong83B:Germany
Address No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN
3SBio Inc is an investment holding company. It is a primary biotechnology company. The company is principally engaged in the development, production, marketing and sale of biopharmaceutical products in the People's Republic of China. The group has only one operating segment. It has presence in Chinese mainland, USA, Other countries/regions. The majority of revenue comes from USA. The core commercialized products of the group include several bio-pharmaceutical drugs, namely, TPIAO, recombinant human erythropoietin (rhEPO) products EPIAO and SEPO, Yisaipu and Cipterbin, and a small molecule drug, Mandi series of minoxidil drugs.
90GF Score

Get the complete analysis for TRSBF

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.15
Price
$1.61
GF Value